Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations
Aditya K. Padhi, Aniruddha Seal, Javed Masood Khan, et al.
European Journal of Pharmacology (2020) Vol. 894, pp. 173836-173836
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

CB-Dock2: improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting
Yang Liu, Xiaocong Yang, Jianhong Gan, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. W1, pp. W159-W164
Open Access | Times Cited: 597
Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241
Cell entry by SARS-CoV-2
Ruchao Peng, Lian-Ao Wu, Qingling Wang, et al.
Trends in Biochemical Sciences (2021) Vol. 46, Iss. 10, pp. 848-860
Open Access | Times Cited: 149
A Global Picture: Therapeutic Perspectives for COVID-19
Vivek P. Chavda, Carron Kapadia, Shailvi Soni, et al.
Immunotherapy (2022) Vol. 14, Iss. 5, pp. 351-371
Open Access | Times Cited: 71
Accelerating COVID-19 Research Using Molecular Dynamics Simulation
Aditya K. Padhi, Soumya Lipsa Rath, Timir Tripathi
The Journal of Physical Chemistry B (2021) Vol. 125, Iss. 32, pp. 9078-9091
Closed Access | Times Cited: 66
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
Antiviral Protein–Protein Interaction Inhibitors
Violeta Marković, Anna Szczepańska, Łukasz Berlicki
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3205-3231
Open Access | Times Cited: 10
A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites
Md. Jahirul Islam, Nafisa Nawal Islam, Md. Siddik Alom, et al.
Immunobiology (2022) Vol. 228, Iss. 1, pp. 152302-152302
Open Access | Times Cited: 35
Enabling dual valorization of lignocellulose by fluorescent lignin carbon dots and biochar-supported persulfate activation: Towards waste-treats-pollutant
Jun Guo, Jikun Xu, Xinyan Liu, et al.
Journal of Hazardous Materials (2022) Vol. 435, pp. 129072-129072
Closed Access | Times Cited: 29
Identification of Pyrazole Derivatives of Usnic Acid as Novel Inhibitor of SARS-CoV-2 Main Protease Through Virtual Screening Approaches
Miah Roney, Gagandeep Singh, AKM Moyeenul Huq, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 4, pp. 696-706
Open Access | Times Cited: 16
Is BF.7 more infectious than other Omicron subtypes: Insights from structural and simulation studies of BF.7 spike RBD variant
J Singh, Shashi Anand, Sandeep Kumar Srivastava
International Journal of Biological Macromolecules (2023) Vol. 238, pp. 124154-124154
Open Access | Times Cited: 13
Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain
Eleni Pitsillou, Julia Liang, Raymond C. Beh, et al.
Computers in Biology and Medicine (2022) Vol. 149, pp. 106035-106035
Open Access | Times Cited: 19
A guide to COVID‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS‐CoV‐2 infection
Drugan K. Brady, Aashi R. Gurijala, Liyu Huang, et al.
FEBS Journal (2022) Vol. 291, Iss. 8, pp. 1632-1662
Open Access | Times Cited: 19
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2
Adel S. Girgis, Siva S. Panda, Benson M. Kariuki, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6603-6603
Open Access | Times Cited: 10
Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics
Sriram Kumar, Duygu Merve Çalışkan, Josua Janowski, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD)
Dwipanjan Sanyal, Suharto Banerjee, Aritra Bej, et al.
International Journal of Biological Macromolecules (2022) Vol. 217, pp. 492-505
Open Access | Times Cited: 17
Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with SARS‐CoV ‐2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticals
Ishrat Husain, Rumana Ahmad, Sahabjada Siddiqui, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 10
Open Access | Times Cited: 16
In silico evaluation of usnic acid derivatives to discover potential antibacterial drugs against DNA gyrase B and DNA topoisomerase IV
Miah Roney, Abdul Rashid Issahaku, Md Shaekh Forid, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 24, pp. 14904-14913
Closed Access | Times Cited: 9
COVID19-inhibitory activity of withanolides involves targeting of the host cell surface receptor ACE2: insights from computational and biochemical assays
Rajkumar Singh Kalra, Vipul Kumar, Jaspreet Kaur Dhanjal, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 17, pp. 7885-7898
Open Access | Times Cited: 22
Solid-liquid phase equilibrium, Hansen solubility parameters and thermodynamic behavior of Arbidol hydrochloride monohydrate in eleven mono-solvents
Chuntao Zhang, Ting Wen, Mengqi Jiang, et al.
Journal of Molecular Liquids (2021) Vol. 346, pp. 118300-118300
Closed Access | Times Cited: 20
SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility
Mariana Valério, Luís Borges-Araújo, Manuel N. Melo, et al.
Frontiers in Medical Technology (2022) Vol. 4
Open Access | Times Cited: 15
Comprehensive role of SARS‐CoV‐2 spike glycoprotein in regulating host signaling pathway
Shuvomoy Banerjee, Xinyu Wang, Shujuan Du, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4071-4087
Open Access | Times Cited: 14
Insights from in silico exploration of major curcumin analogs targeting human dipeptidyl peptidase IV
Miah Roney, Amit Dubey, Abdul Rashid Issahaku, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access | Times Cited: 2
Designing Spherical Particles of Arbidol Hydrochloride via Spherical Crystallization: Preparation and Characterization
Xinqiao Wang, Zongqi Li, Chuntao Zhang, et al.
Industrial & Engineering Chemistry Research (2024) Vol. 63, Iss. 12, pp. 5249-5260
Closed Access | Times Cited: 2
Deep learning-based molecular dynamics simulation for structure-based drug design against SARS-CoV-2
Yao Sun, Yanqi Jiao, Chengcheng Shi, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 5014-5027
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top